Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Esperion Therapeutics, Inc. (ESPR) had Return on Investments of 15.47% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$87.31M |
|
$-31.33M |
|
$41.29M |
|
$46.02M |
|
$97.27M |
|
$-9.96M |
|
$-21.37M |
|
$-31.33M |
|
$-31.33M |
|
$-31.33M |
|
$-31.33M |
|
$-31.33M |
|
$-31.33M |
|
$-9.96M |
|
$-9.09M |
|
200.74M |
|
200.74M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$360.46M |
|
$0.17M |
|
$3.56M |
|
$364.02M |
|
$359.03M |
|
$248.78M |
|
$456.35M |
|
$815.38M |
|
$-451.36M |
|
$-451.42M |
|
$-451.36M |
|
205.43M |
|
| Cash Flow Statement Financials | |
$-58.34M |
|
-- |
|
$6.02M |
|
$144.76M |
|
$92.45M |
|
$-52.31M |
|
$7.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.00 |
|
-- |
|
-- |
|
-1.23 |
|
-0.67 |
|
52.71% |
|
-11.41% |
|
-11.41% |
|
-- |
|
-35.89% |
|
-35.89% |
|
$-58.34M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
0.38 |
|
0.73 |
|
122.65 |
|
6.94% |
|
6.94% |
|
-8.61% |
|
|
Return on Investments |
15.47% |
$-2.20 |
|
$-0.29 |
|
$-0.29 |
|